US20070201736A1 - System and method for vascular border detection - Google Patents

System and method for vascular border detection Download PDF

Info

Publication number
US20070201736A1
US20070201736A1 US11/786,599 US78659907A US2007201736A1 US 20070201736 A1 US20070201736 A1 US 20070201736A1 US 78659907 A US78659907 A US 78659907A US 2007201736 A1 US2007201736 A1 US 2007201736A1
Authority
US
United States
Prior art keywords
data
border
image
vascular
gradient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/786,599
Inventor
Jon Klingensmith
Anuja Nair
Barry Kuban
D. Vince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/786,599 priority Critical patent/US20070201736A1/en
Publication of US20070201736A1 publication Critical patent/US20070201736A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0858Detecting organic movements or changes, e.g. tumours, cysts, swellings involving measuring tissue layers, e.g. skin, interfaces

Definitions

  • the present invention relates to vascular images, or more particularly, to a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a corresponding vascular image.
  • RF radio frequency
  • the present invention relates to medical imaging arts. It finds particular application to a system and method of identifying a border on a vascular image (e.g., intra-vascular ultrasound (IVUS) image, Virtual HistologyTM (VH) image, etc.).
  • IVUS intra-vascular ultrasound
  • VH Virtual HistologyTM
  • the present invention is described in terms of identifying a luminal and medial-adventitial border on an IVUS or VH image, the present invention is not so limited. Thus, for example, identifying any border (or boundary) on any vascular image is within the spirit and scope of the present invention.
  • Ultrasonic imaging of portions of a patient's body provides a useful tool in various areas of medical practice for determining the best type and course of treatment.
  • Imaging of the coronary vessels of a patient by ultrasonic techniques can provide physicians with valuable information.
  • the image data may show the extent of a stenosis in a patient, reveal progression of disease, help determine whether procedures such as angioplasty or atherectomy are indicated or whether more invasive procedures may be warranted.
  • an ultrasonic transducer is attached to the end of a catheter that is carefully maneuvered through a patient's body to a point of interest such as within a blood vessel.
  • the transducer may be a single-element crystal or probe that is mechanically scanned or rotated back and forth to cover a sector over a selected angular range.
  • Acoustic signals are then transmitted and echoes (or backscatter) from these acoustic signals are received.
  • the backscatter data can be used to identify the type of a scanned tissue.
  • an image of the blood vessel e.g., an IVUS image
  • This image is then visually analyzed by a cardiologist to assess the vessel components and plaque content.
  • a typical analysis includes determining the size of the lumen and amount of plaque in the vessel. This is performed by generating an image of the vessel (e.g., an IVUS image) and manually drawing contoured boundaries on the image where the clinician believes the luminal and the medial-adventitial borders are located.
  • the luminal border which demarcates the blood-intima interface
  • the medial-adventitial border which demarcates the external elastic membrane or the boundary between the media and the adventitia, are manually drawn to identify the plaque-media complex that is located there between. This is a very time consuming process.
  • the present invention provides a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a vascular image.
  • a data gathering device e.g., an intra-vascular ultrasound (IVUS) device, etc.
  • IVUS intra-vascular ultrasound
  • the transducer is inserted into a blood vessel of a patient and used to gather radio frequency (RF) data backscattered from vascular tissue.
  • the RF data is then provided to (or acquired by) the computing device via the data-gathering device.
  • the computing device includes at least one data storage device (e.g., database, memory, etc.) and at least one application (e.g., a characterization application, a gradient-border application, a frequency-border application and/or an active-contour application).
  • a data storage device is used (at least primarily) to store a plurality of tissue types and related parameters.
  • the information is stored so that each tissue type is linked to at least one corresponding parameter.
  • the RF data (which is typically in the time domain) is provided to the characterization application, where it is converted (or transformed) into the frequency domain.
  • the characterization application is then used to identify a plurality of parameters associated with the transformed RF data (or a portion thereof.
  • the identified parameters are then compared to the parameters stored in the data storage device to identify the corresponding tissue type (or the type of tissue that backscattered the analyzed RF data).
  • tissue type or the type of tissue that backscattered the analyzed RF data.
  • Such a process can be used, for example, to identify portions of RF data (or sets thereof) that are related to at least border-related tissue types (e.g., medial, adventitial, plaque, blood, etc.).
  • the characterization application is further used to identify parameters from the RF data (which is typically in the time domain).
  • Parameters associated with the RF data can be used, for example, to spatially identify certain frequencies (or parameters related thereto).
  • RF data can be used to identify the location of these tissues and the related frequency spectrum can be used to identify tissue types.
  • the identified tissue types and corresponding RF data are provided to the active-contour application.
  • the data is then used to identify at least one border on an image of a vascular object (e.g., intra-vascular ultrasound (IVUS) image, Virtual HistologyTM (VH) image, etc.).
  • IVUS intra-vascular ultrasound
  • VH Virtual HistologyTM
  • RF data corresponding to blood and plaque tissue can be used to identify (or substantially approximate) the luminal border on a vascular image.
  • RF data corresponding to plaque, medial and/or adventitial tissue can be used to identify (or substantially approximate) the medial-adventitial border on a vascular image.
  • the computing device further includes a frequency-border application.
  • the characterization application is adapted to provide the identified information to the frequency-border application, where it is used to determine spectral information.
  • the spectral information is then provided to the active-contour application and used to determine at least one border on a vascular image (i.e., image-border data).
  • the spectral information comprises spectral-force data, or data representing a frequency-based force that is applicable to (or a component on the image-border data.
  • the spectral-information comprises spectral-border data, or data representing an estimation of at least one border on a vascular image.
  • the computing device further includes a gradient-border application.
  • the gradient-border application is adapted to use the acquired RF data to determine gradient information, which can then be used to identify a border or boundary. This is because a change in pixel color (e.g., light-to-dark, dark-to-light, shade1-to-shade2, etc) can indicate the presence of a border.
  • the gradient information comprises gradient-force data, or data that represents a gradient-based force that is applicable to (or a component of) the image-border data.
  • the gradient information comprises gradient-border data, or data that represents an estimation of at least one border on a vascular image (e.g., the IVUS image, a VH image, etc.).
  • the gradient-border data can be used, for example, either alone or together with other border-related information (e.g., spectral information, etc.), to determine at least one border on a vascular image.
  • the active-contour application is further adapted to use other-border information to determine a border on a vascular image.
  • information related to at least one border on another image(s) e.g., a previous image, a subsequent image, multiple images, etc.
  • the active-contour application can be used to adjust the border to more closely match the actual border of the vascular object. This is done by considering, or taking into account continuity data, curvature data, and/or relatedness data.
  • the frequency-border application is further adapted to filter the transformed RF data before it is used to generate spectral information and the gradient-border application is further adapted to process the acquired RF data using traditional IVUS imaging techniques.
  • FIG. 1 illustrates a vascular-border-identification system in accordance with one embodiment of the present invention.
  • FIG. 2 illustrates an exemplary intra-vascular ultrasound (IVUS) image.
  • IVUS intra-vascular ultrasound
  • FIG. 3 illustrates a plurality of borders that are common to IVUS images.
  • FIG. 4 illustrates a plurality of control points on one border of an IVUS image.
  • FIG. 5 illustrates how a plurality of 2D vascular images can be used to generate a 3D vascular image.
  • FIG. 6 illustrates how the control points from the image depicted in FIG. 4 can be extrapolated onto another image.
  • FIG. 7 illustrates a vascular image including a luminal boundary, a medial-adventitial boundary, and a plaque component located therebetween.
  • FIG. 8 illustrates a method of identifying a border of a vascular object in accordance with one embodiment of the present invention.
  • the present invention provides a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a vascular image.
  • RF radio frequency
  • FIG. 1 illustrates a vascular-border-identification system 10 in accordance with one embodiment of the present invention.
  • a data-gathering console 200 is electrically connected to a computing device 100 and a transducer 220 via a catheter 210 .
  • the transducer 220 is inserted into a blood vessel of a patient (not shown) and used to gather radio frequency (RF) data backscattered from vascular tissue.
  • RF radio frequency
  • the RF data is then provided to (or acquired by) the data-gathering device 200 , where it is used (or can be used) to produce an image of the vessel (e.g., intra-vascular ultrasound (IVUS) image, etc.).
  • IVUS intra-vascular ultrasound
  • RF data is typically gathered in segments, either through a rotating transducer or an array of circumferentially positioned transducers, where each segment represents an angular portion of the resultant image.
  • it takes a plurality of segments (or a set of RF data) to image an entire cross-section of a vascular object.
  • multiple sets of RF data are typically gathered from multiple locations within a vascular object (e.g., by moving the transducer linearly through the vessel). These multiple sets of data can then be used to create a plurality of two-dimensional (2D) images or one three-dimensional (3D) image.
  • the data-gathering device 200 includes, but is not limited to, an IVUS console, thermographic device, optical device (e.g., an optical coherence tomography (OCT) console), MRI device, or any vascular imaging device generally known to those skilled in the art.
  • OCT optical coherence tomography
  • the computing device 100 depicted in FIG. 1 includes, but its not limited to, a personal computer or any other data-processing device (general purpose or application specific) that is generally known to those skilled in the art.
  • the RF data (or multiple sets thereof is provided to (or acquired by) the computing device 100 .
  • the computing device 100 includes at least one data storage device (e.g., database 130 , memory 150 ) and a plurality of applications (e.g., a characterization application 110 , a gradient-border application 120 , a frequency-border application 140 and/or an active-contour application 160 ).
  • the RF data provided to (or acquire by) the computing device 100 is gated to electrocardiogram (ECG) information.
  • ECG electrocardiogram
  • a plurality of tissue types e.g., medial, adventitial, plaque, blood, etc.
  • the information is stored so that each tissue type is linked to its corresponding parameters.
  • each tissue type can be identified (or defined) by the parameters that are linked thereto.
  • the term parameter includes, but is not limited to maximum power, minimum power, frequencies at maximum and/or minimum power, y intercepts (estimated or actual), slope, mid-band fit, integrated backscatter, tissue depth, and all parameters (either time or frequency based) generally known to (or discernable by) those skilled in the art.
  • tissue type includes, but is not limited to, blood tissue, plaque tissue (e.g., calcified tissues, fibrous tissues, calcified-necrotic tissues and fibro-lipidic tissues), medial tissue, adventitial tissue, and all other vascular tissues, or combinations thereof (e.g., medial-adventitial tissue), generally known to those skilled in the art.
  • plaque tissue e.g., calcified tissues, fibrous tissues, calcified-necrotic tissues and fibro-lipidic tissues
  • medial tissue e.g., adventitial tissue, and all other vascular tissues, or combinations thereof (e.g., medial-adventitial tissue), generally known to those skilled in the art.
  • data storage devices depicted herein include, but are not limited to, RAM, cache memory, flash memory, magnetic disks, optical disks, removable disks, SCSI disks, IDE hard drives, tape drives and all other types of data storage devices (and combinations thereof, such as RAID devices) generally known to those skilled in the art.
  • the RF data (which is typically in the time domain) is provided to the characterization application 110 , where it is converted (or transformed) into the frequency domain.
  • the characterization application 110 is then used to identify a plurality of parameters associated with the transformed RF data (or a portion thereof.
  • the identified parameters are then compared to the parameters stored in the database 130 to identify the corresponding tissue type (or the type of tissue that backscattered the analyzed RF data).
  • tissue type or the type of tissue that backscattered the analyzed RF data.
  • Such a process can be used (e.g., once or repeatedly) to identify the portions of RF data (or sets thereof) that are associated with each stored tissue type (e.g., medial, adventitial, plaque, blood, etc.).
  • the frequency conversion (or transformation) discussed herein includes, but is not limited to, the use of a fast Fourier transformation (FFT), the Welch periodogram, autoregressive power spectrum (AR) analysis, or any other frequency transformation or spectral analysis generally known to those skilled in the art.
  • FFT fast Fourier transformation
  • AR autoregressive power spectrum
  • the RF data may either be received in real-time (e.g., while the patient is in the operating room) or after a period of delay (e.g., via CD-ROM, etc.).
  • the identified parameters should be related (generally) to the stored parameters.
  • an estimated Y intercept parameter should be identified if data related to a signal's estimated Y intercept is stored in the database 130 and linked to at least one tissue type.
  • the characterization application 110 is further used to identify parameters from the RF data (which is typically in the time domain).
  • Parameters associated with the RF data can be used, for example, to spatially identify certain frequencies (or parameters related thereto).
  • RF data can be used to identify the location of these tissues and the related frequency spectrum can be used to identify tissue types.
  • the use of parameters to identify tissue types is discussed in detail in U.S. Pat. No. 6,200,268, which was issued on Mar. 13, 2001, and U.S. patent application Ser. No. 10/647,971, which was filed on Aug. 25, 2003, and are incorporated herein, in their entireties, by reference.
  • the RF data (or a transformation thereof and the identified tissue types (including the association therebetween) are provided to the active-contour application 160 .
  • This data is then used to identify at least one border on an image of a vascular object (e.g., intra-vascular ultrasound (IVUS) image, Virtual HistologyTM, (VH) image, etc.).
  • IVUS intra-vascular ultrasound
  • VH Virtual HistologyTM
  • RF data corresponding to blood and plaque tissue can be used to identify (or substantially approximate) the luminal border on a vascular image.
  • RF data corresponding to plaque, medial, and/or adventitial tissue can be used to identify (or substantially approximate) the medial-adventitial border on a vascular image.
  • the present invention is not limited to the identification of any particular border (or boundary) on a vascular image, and includes all borders generally known to those skilled in the art.
  • the applications depicted and discussed herein e.g., characterization application 110 , gradient-border application 120 , frequency-border application 140 , active-contour application 160 ), may exist as a single application or as multiple applications, locally and/or remotely stored.
  • the number and location of the components depicted in FIG. 1 are not intended to limit the present invention, and are merely provided to illustrate the environment in which the present invention may operate.
  • a computing device having a single data storage device and/or a remotely located characterization application is within the spirit-and scope of the present invention.
  • the computing device 100 further includes a frequency-border application 140 .
  • the characterization application 110 is adapted to provide the RF data (or a transformation thereof and the identified tissue types (including the association therebetween) to the frequency-border application 140 , where it is used to determine spectral information.
  • the spectral information is then provided to the active-contour application 160 and used to determine at least one border on a vascular image (i.e., image-border data).
  • the spectral information comprises spectral-force data.
  • Spectral-force data is based (either directly or indirectly) on the information provided by the characterization application 110 and represents a frequency-based force that is applicable to (or a component of the image-border data.
  • the spectral-force data can be used, for example, to determine or refine the image-border data (e.g., as determined by the active-contour application 160 ).
  • spectral-force data can be used together with other border-related information to determine a border on a vascular image, or applied to a border determined using border-related information (e.g., as an external force).
  • the resultant border is based, at least in part, on the spectral-force data.
  • spectral-force data can be analogized to a gravitation field, in which the force (or field) is used to attract a border in a given direction, or to have a given shape.
  • the strength of the force (or gravitational pull) is directly proportional to the relatedness of the corresponding RF data to a border-related tissue type(s).
  • the spectral information comprises spectral-border data.
  • Spectral-border data is based (either directly or indirectly) on the information provided by the characterization application 110 and represents an estimation of at least one border on a vascular image.
  • the spectral-border data can be used, for example, either alone or together with other border-related information, to determine image-border data (e.g., as determined by the active-contour application 160 ).
  • image-border data e.g., as determined by the active-contour application 160 .
  • spectral information is not limited to spectral-force data and/or spectral-border data, but further includes any data resulting from a spectral analysis of the acquired RF data.
  • the frequency-border application 140 is further adapted to filter the transformed RF data before it is used to generate spectral information. Specifically, in one embodiment of the present invention, a portion of the vascular object is selected. The corresponding transformed RF data and the information stored in the database 130 are then used to identify the tissue types that are related thereto. The minority tissue type is then filtered out. This can be accomplished, for example, by reassigning the RF data associated with the minority tissue type, so that it is associated with the majority tissue types.
  • a first portion (or ninety-five percent) of the corresponding RF data is associate with blood tissue and a second portion (or five percent) of the corresponding RF data is associated with plaque tissue, then the second portion would be reassigned so that it is associate with blood tissue (i.e., making a homogenous composition).
  • the present invention is not limited to such a filtering algorithm, and includes any other filtering algorithms generally known to those skilled in the art.
  • the computing device 100 further includes a gradient-border application 120 .
  • the gradient-border application 120 is adapted to use the acquired RF data to determine gradient information, which can then be used to identify a border or boundary (e.g., used by the gradient-border application 120 to estimate at least one border, provided to the active-contour application and used together with spectral information to determine image-border data, etc.). This is because a change in pixel color (e.g., light-to-dark, dark-to-light, shade1-to-shade2, etc) can indicate the presence of a border.
  • a border or boundary e.g., used by the gradient-border application 120 to estimate at least one border, provided to the active-contour application and used together with spectral information to determine image-border data, etc.
  • FIG. 2 illustrates an exemplary IVUS image 20 of a vascular object.
  • the catheter can be identified by the first light-to-dark transition (or gradient).
  • the catheter border is further identified in FIG. 3 (i.e., 330 ).
  • the next dark-to-light transition or gradient
  • the medial-adventitial border can then be identified by going outward from the luminal border until the next dark-to-light transition (or gradient) is found (see FIG. 3, 310 ).
  • the IVUS image is constructed using gray-scales, it may be necessary to utilize an algorithm and/or at least one threshold value to identify precisely where the image changes from light to dark (or vice versa).
  • the present invention is not limited to any particular algorithm for identifying the aforementioned transitions, and includes all algorithms (and/or threshold values) generally known to those skilled in the art.
  • the gradient-border application 120 is further adapted to process the acquired RF data using traditional IVUS imaging techniques.
  • the gradient-border application 120 may be adapted to filter the RF data (e.g., using a highpass filter, etc.), detect relevant portions (e.g., envelope detection, etc.), and/or modulate any portion thereof (e.g., smoothing, log compressing, etc.). Such techniques are all well known to those skilled in the art.
  • the resultant data can then be used to produce an IVUS image or determine gradient information.
  • the gradient information comprises gradient-force data.
  • Gradient-force data is based (either directly or indirectly) on the gradients in an IVUS image and represents a gradient-based force that is applicable to (or a component on the image-border data.
  • the gradient-force data can be used, for example, to determine or refine the image-border data (e.g., as determined by the active-contour application 160 ).
  • gradient-force data can be used together with other border-related information to determine a border on a vascular image, or applied to a border determined using border-related information (e.g., as an external force).
  • the resultant border is based, at least in part, on the gradient-force data.
  • gradient-force data can be analogized to a gravitation field, in which the force (or field) is used to attract a border in a given direction, or to have a given shape.
  • the strength of the force is directly proportional to the gradients in the IVUS image (or transitions therein).
  • the gradient information comprises gradient-border data.
  • Gradient-border data is based (either directly or indirectly) on the gradients in an IVUS image and represents an estimation of at least one border on a vascular image (e.g., the IVUS image, a VH image, etc.).
  • the gradient-border data can be used, for example, either alone or together with other border-related information (e.g., spectral information, etc.), to determine at least one border on a vascular image.
  • border-related information e.g., spectral information, etc.
  • the active-contour application 160 is further adapted to use other-border information to determine a border on a vascular image.
  • information related to a border on another image(s) e.g., a previous image, a subsequent image, multiple images, etc.
  • the active-contour application 160 is further adapted to use other-border information to determine a border on a vascular image.
  • information related to a border on another image(s) e.g., a previous image, a subsequent image, multiple images, etc.
  • the active-contour application 160 is further adapted to use other-border information to determine a border on a vascular image.
  • information related to a border on another image(s) e.g., a previous image, a subsequent image, multiple images, etc.
  • the border-detection algorithm 160 is adapted to identify at least one control point on the border of another image.
  • the border-detection algorithm can be used, for example, to identify a plurality of control points 22 on the luminal border 320 .
  • the location and number of control points depicted in FIG. 4 are not intended to limit the present invention, and are merely provided to illustrate the environment in which the present invention may operate.
  • the active-contour application 160 is adapted to identify a border using user-identified control points. Such an embodiment is discussed in detail in U.S. Pat. No. 6,381,350, which was issued on Apr. 30, 2002, and is incorporated herein, in its entirety, by reference.
  • the active-contour application 160 can be used to identify at least one control point on the current vascular image. In one embodiment of the present invention, this is done by extrapolating the previously identified control points to the current vascular image. By doing this, multiple 2D images (or at least one 3D image) can be produced. For example, as illustrated in FIG. 5 , multiple 2D images (e.g., 20 , 52 a - 52 d, etc.) are used to produce a 3D image of a tubular (e.g., vascular) object 50 . It should be appreciated that a memory device 150 (see FIG. 1 ) can be used to store information related to this embodiment (e.g., a border on another image, control points on such a border, extrapolated control points, resulting image-border data, etc.).
  • information related to this embodiment e.g., a border on another image, control points on such a border, extrapolated control points, resulting image-border data, etc.
  • FIG. 6 illustrates one method as to how an identified control point can be extrapolated to the current vascular image.
  • the control points that were illustrated in FIG. 4 i.e., 22
  • the current image e.g., 52 d
  • the control points are extrapolated using Cartesian coordinates.
  • FIG. 6 illustrates control points being extrapolated to an adjacent image, the present invention is not so limited.
  • extracting control points to (or from) additional images is within the spirit and scope of the present invention.
  • the active-contour application 160 is further adapted to identify (or approximate) a border based on the extrapolated points.
  • the extrapolated points 62 may be connected using a plurality of lines 64 , where the lines are either straight or curved (not shown).
  • the extrapolating application is adapted to use an algorithm (e.g., a cubic-interpolation algorithm, etc.) to identify line shape. Border extrapolation is discussed in detail in U.S. patent application Ser. No. 10/647,473, which was filed Aug. 26, 2003, and is incorporated herein, in its entirety, by reference.
  • the active-contour application 160 is then used to adjust the border to more closely match the actual border of the vascular object.
  • the active-contour application 160 may consider, or take into account, at least (i) the proximity of the border to each extrapolated point (i.e., continuity or control-point factor), (ii) border curvature or smoothness (i.e., curvature or boundary factor), and/or (iii) the relationship between multiple borders (i.e., relatedness factor). For example, by considering a continuity or control-point factor, the border can be adjusted so that it passes through each extrapolated point.
  • the border can be adjusted to prevent sharp transitions (e.g., corners, etc.). Furthermore, by considering a relatedness factor, multiple borders can be adjusted in relation to one another (e.g., the luminal border can always be located inside the medial-adventitial border, etc.).
  • these three factors are also used to determine related borders on adjacent images. It should be appreciated that if multiple factors are being considered, then individual factors may be weighted more heavily than others. This becomes important if the factors produce different results. It should further be appreciated that the present invention is not limited to the use of the aforementioned factors for border optimization, and that the use of additional factors to adjust (or optimize) a border is within the spirit and scope of the present invention.
  • the adjusted borders are configured to be manually manipulated. In other words, at least one point on the border can be selected and manually moved to a new location.
  • the active-contour application 160 is then used (as previously discussed) to reconstruct the border accordingly.
  • the active-contour application is further adapted to adjust related borders in adjacent images. This is done by fitting a geometrical model (e.g., a tensor product B-spline, etc.) over the surface of a plurality of related borders (e.g., as identified on multiple IVUS images). A plurality of points on the geometrical model are then parameterized and formulated into a constrained least-squares system of equations. If a point on the border is manually moved, the active-contour application can utilize these equations to calculate a resulting surface (or mesh of control points). The affected borders (e.g., adjacent borders) can then be adjusted accordingly.
  • a geometrical model e.g., a tensor product B-spline, etc.
  • the active-contour application 160 can either be used (e.g., initiated) to identify a single border on a vascular image, thus requiring a subsequent use to identify another border on the vascular image, or used (e.g., initiated) to identify multiple borders on a vascular image.
  • the multiple borders are identified at substantially the same time.
  • the multiple borders can then be imaged (in either 2D or 3D) and analyzed by either a skilled practitioner or a computer algorithm.
  • the luminal border 74 and the medial-adventitial border 76 can be used (by either a clinician or an algorithm) to identify the plaque-media complex 78 of a vascular object.
  • FIG. 8 One method of identifying a border on a vascular image is illustrated in FIG. 8 .
  • RF data backscattered from vascular tissue is acquired.
  • the RF data is then (i) transformed from the time domain into the frequency domain and (ii) processed using traditional IVUS imaging techniques, at steps 810 and 820 , respectively.
  • a plurality of parameters are identified at step 812 , and compared to stored parameters, at step 814 , to identify a plurality of tissue types.
  • RF data (or a transformation thereof) that corresponds to at least relevant (e.g., border-related) tissue types is identified.
  • the corresponding RF data is then used to determine spectral information (e.g., spectral-force data, spectral-border data, etc.) at step 818 .
  • spectral information e.g., spectral-force data, spectral-border data, etc.
  • gradients are used to determine gradient information (e.g., gradient-force data, gradient-border data, etc.) at step 822 .
  • other-border data e.g., data related to at least one border on at least one other image
  • the gradient information and spectral information are used to modify the at least one border on the current vascular image, ending the method at step 828 .
  • the present invention is not limited to the method illustrated in FIG. 8 , and further includes all methods of operation generally described or suggested herein or discernable by one skilled in art. For example, a method that uses only spectral information to determine at least one border on a vascular image is within the spirit and scope of the present invention.

Abstract

The present invention uses a radio frequency (RF) signal backscattered from vascular tissue to identify a border on a vascular image. Embodiments of the invention operate in accordance with a data gathering device connected to a computing device and a transducer via a catheter. The transducer is used to gather RF data backscattered from vascular tissue. The RF data is provided to the computing device via the data-gathering device. In one embodiment of the present invention, the computing device includes (i) a data storage device for storing tissue types and related parameters and (ii) an application. The application is used to convert the RF data into the frequency domain and to identify associated parameters. The parameters are compared to the parameters stored in the data storage device to identify the corresponding tissue type. This information is used, possibly with other border-related information, to determine a border on a vascular image.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 10/837,352, filed Apr. 29, 2004, which claimed the benefit pursuant to 35 U.S.C. § 119(e) of U.S. Provisional Patent Application No. 60/550,620, filed Mar. 4, 2004, all of which are hereby expressly incorporated by reference in their entirety for all purposes.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to vascular images, or more particularly, to a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a corresponding vascular image.
  • 2. Description of Related Art
  • The present invention relates to medical imaging arts. It finds particular application to a system and method of identifying a border on a vascular image (e.g., intra-vascular ultrasound (IVUS) image, Virtual Histology™ (VH) image, etc.). It should be appreciated that while the present invention is described in terms of identifying a luminal and medial-adventitial border on an IVUS or VH image, the present invention is not so limited. Thus, for example, identifying any border (or boundary) on any vascular image is within the spirit and scope of the present invention.
  • Ultrasonic imaging of portions of a patient's body provides a useful tool in various areas of medical practice for determining the best type and course of treatment. Imaging of the coronary vessels of a patient by ultrasonic techniques can provide physicians with valuable information. For example, the image data may show the extent of a stenosis in a patient, reveal progression of disease, help determine whether procedures such as angioplasty or atherectomy are indicated or whether more invasive procedures may be warranted.
  • In a typical ultrasound imaging system, an ultrasonic transducer is attached to the end of a catheter that is carefully maneuvered through a patient's body to a point of interest such as within a blood vessel. The transducer may be a single-element crystal or probe that is mechanically scanned or rotated back and forth to cover a sector over a selected angular range. Acoustic signals are then transmitted and echoes (or backscatter) from these acoustic signals are received. The backscatter data can be used to identify the type of a scanned tissue. As the probe is swept through the sector, many acoustic lines are processed building up a sector-shaped image of the patient. After the data is collected, an image of the blood vessel (e.g., an IVUS image) can be reconstructed using well-known techniques. This image is then visually analyzed by a cardiologist to assess the vessel components and plaque content.
  • A typical analysis includes determining the size of the lumen and amount of plaque in the vessel. This is performed by generating an image of the vessel (e.g., an IVUS image) and manually drawing contoured boundaries on the image where the clinician believes the luminal and the medial-adventitial borders are located. In other words, the luminal border, which demarcates the blood-intima interface, and the medial-adventitial border, which demarcates the external elastic membrane or the boundary between the media and the adventitia, are manually drawn to identify the plaque-media complex that is located there between. This is a very time consuming process. Furthermore, this process is made more difficult when multiple images are being analyzed (e.g., to recreate a 3D vascular image, etc.) or the images are of poor quality (e.g., making the boundaries more difficult to see). Thus, it would be advantageous to have a system and method of identifying a border on a vascular image that overcomes at least one of these drawbacks.
  • SUMMARY OF THE INVENTION
  • The present invention provides a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a vascular image. Embodiments of the present invention operate in accordance with a data gathering device (e.g., an intra-vascular ultrasound (IVUS) device, etc.) electrically connected to a computing device and a transducer via a catheter. The transducer is inserted into a blood vessel of a patient and used to gather radio frequency (RF) data backscattered from vascular tissue. The RF data is then provided to (or acquired by) the computing device via the data-gathering device.
  • In a preferred embodiment of the present invention, the computing device includes at least one data storage device (e.g., database, memory, etc.) and at least one application (e.g., a characterization application, a gradient-border application, a frequency-border application and/or an active-contour application). A data storage device is used (at least primarily) to store a plurality of tissue types and related parameters. Preferably, the information is stored so that each tissue type is linked to at least one corresponding parameter.
  • In one embodiment of the present invention, the RF data (which is typically in the time domain) is provided to the characterization application, where it is converted (or transformed) into the frequency domain. The characterization application is then used to identify a plurality of parameters associated with the transformed RF data (or a portion thereof. The identified parameters are then compared to the parameters stored in the data storage device to identify the corresponding tissue type (or the type of tissue that backscattered the analyzed RF data). Such a process can be used, for example, to identify portions of RF data (or sets thereof) that are related to at least border-related tissue types (e.g., medial, adventitial, plaque, blood, etc.).
  • In another embodiment of the present invention, the characterization application is further used to identify parameters from the RF data (which is typically in the time domain). Parameters associated with the RF data (or a portion thereof can be used, for example, to spatially identify certain frequencies (or parameters related thereto). Thus, for example, if a vascular wall comprises multiple tissue layers, corresponding RF data can be used to identify the location of these tissues and the related frequency spectrum can be used to identify tissue types.
  • The identified tissue types and corresponding RF data (or transformations thereof (i.e., identified information) are provided to the active-contour application. The data is then used to identify at least one border on an image of a vascular object (e.g., intra-vascular ultrasound (IVUS) image, Virtual Histology™ (VH) image, etc.). For example, RF data corresponding to blood and plaque tissue can be used to identify (or substantially approximate) the luminal border on a vascular image. Similarly, RF data corresponding to plaque, medial and/or adventitial tissue can be used to identify (or substantially approximate) the medial-adventitial border on a vascular image.
  • In another embodiment of the present invention, the computing device further includes a frequency-border application. In this embodiment, the characterization application is adapted to provide the identified information to the frequency-border application, where it is used to determine spectral information. The spectral information is then provided to the active-contour application and used to determine at least one border on a vascular image (i.e., image-border data). In one embodiment of the present invention, the spectral information comprises spectral-force data, or data representing a frequency-based force that is applicable to (or a component on the image-border data. In another embodiment of the present invention, the spectral-information comprises spectral-border data, or data representing an estimation of at least one border on a vascular image.
  • In one embodiment of the present invention, the computing device further includes a gradient-border application. The gradient-border application is adapted to use the acquired RF data to determine gradient information, which can then be used to identify a border or boundary. This is because a change in pixel color (e.g., light-to-dark, dark-to-light, shade1-to-shade2, etc) can indicate the presence of a border. In another embodiment of the present invention, the gradient information comprises gradient-force data, or data that represents a gradient-based force that is applicable to (or a component of) the image-border data. In another embodiment of the present invention, the gradient information comprises gradient-border data, or data that represents an estimation of at least one border on a vascular image (e.g., the IVUS image, a VH image, etc.). The gradient-border data can be used, for example, either alone or together with other border-related information (e.g., spectral information, etc.), to determine at least one border on a vascular image.
  • In another embodiment of the present invention, the active-contour application is further adapted to use other-border information to determine a border on a vascular image. In other words, information related to at least one border on another image(s) (e.g., a previous image, a subsequent image, multiple images, etc.) is used to determine (or approximate) at least one border on the vascular image at issue (i.e., the current vascular image). In another embodiment of the present invention, the active-contour application can be used to adjust the border to more closely match the actual border of the vascular object. This is done by considering, or taking into account continuity data, curvature data, and/or relatedness data.
  • In other embodiments of the present invention, the frequency-border application is further adapted to filter the transformed RF data before it is used to generate spectral information and the gradient-border application is further adapted to process the acquired RF data using traditional IVUS imaging techniques. A more complete understanding of the system and method of identifying a border on an IVUS image will be afforded to those skilled in the art, as well as a realization of additional advantages and objects thereof, by a consideration of the following detailed description of the preferred embodiment. Reference will be made to the appended sheets of drawings which will first be described briefly.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a vascular-border-identification system in accordance with one embodiment of the present invention.
  • FIG. 2 illustrates an exemplary intra-vascular ultrasound (IVUS) image.
  • FIG. 3 illustrates a plurality of borders that are common to IVUS images.
  • FIG. 4 illustrates a plurality of control points on one border of an IVUS image.
  • FIG. 5 illustrates how a plurality of 2D vascular images can be used to generate a 3D vascular image.
  • FIG. 6 illustrates how the control points from the image depicted in FIG. 4 can be extrapolated onto another image.
  • FIG. 7 illustrates a vascular image including a luminal boundary, a medial-adventitial boundary, and a plaque component located therebetween.
  • FIG. 8 illustrates a method of identifying a border of a vascular object in accordance with one embodiment of the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The present invention provides a system and method of using the frequency spectrum of a radio frequency (RF) signal backscattered from vascular tissue to identify at least one border on a vascular image. In the detailed description that follows, like element numerals are used to describe like elements illustrated in one or more figures.
  • Embodiments of the present invention operate in accordance with a data-gathering device and a computing device electrically connected thereto. FIG. 1 illustrates a vascular-border-identification system 10 in accordance with one embodiment of the present invention. Specifically, a data-gathering console 200 is electrically connected to a computing device 100 and a transducer 220 via a catheter 210. The transducer 220 is inserted into a blood vessel of a patient (not shown) and used to gather radio frequency (RF) data backscattered from vascular tissue. The RF data is then provided to (or acquired by) the data-gathering device 200, where it is used (or can be used) to produce an image of the vessel (e.g., intra-vascular ultrasound (IVUS) image, etc.).
  • More particularly, RF data is typically gathered in segments, either through a rotating transducer or an array of circumferentially positioned transducers, where each segment represents an angular portion of the resultant image. Thus, it takes a plurality of segments (or a set of RF data) to image an entire cross-section of a vascular object. Furthermore, multiple sets of RF data are typically gathered from multiple locations within a vascular object (e.g., by moving the transducer linearly through the vessel). These multiple sets of data can then be used to create a plurality of two-dimensional (2D) images or one three-dimensional (3D) image. It should be appreciated that the data-gathering device 200 includes, but is not limited to, an IVUS console, thermographic device, optical device (e.g., an optical coherence tomography (OCT) console), MRI device, or any vascular imaging device generally known to those skilled in the art. It should further be appreciated that the computing device 100 depicted in FIG. 1 includes, but its not limited to, a personal computer or any other data-processing device (general purpose or application specific) that is generally known to those skilled in the art.
  • The RF data (or multiple sets thereof is provided to (or acquired by) the computing device 100. In one embodiment of the present invention, the computing device 100 includes at least one data storage device (e.g., database 130, memory 150) and a plurality of applications (e.g., a characterization application 110, a gradient-border application 120, a frequency-border application 140 and/or an active-contour application 160). In a preferred embodiment of the present application, the RF data provided to (or acquire by) the computing device 100 is gated to electrocardiogram (ECG) information. The concept of gating RF data is in discussed in detail in U.S. patent application Ser. No. 10/647,977, which was filed Aug. 25, 2003, and is incorporated herein, in its entirety, by reference.
  • In a first embodiment of the present invention, a plurality of tissue types (e.g., medial, adventitial, plaque, blood, etc.) and related parameters are stored in a database 130. Preferably, the information is stored so that each tissue type is linked to its corresponding parameters. By doing so, each tissue type can be identified (or defined) by the parameters that are linked thereto. It should be appreciated that the term parameter, as that term is used herein, includes, but is not limited to maximum power, minimum power, frequencies at maximum and/or minimum power, y intercepts (estimated or actual), slope, mid-band fit, integrated backscatter, tissue depth, and all parameters (either time or frequency based) generally known to (or discernable by) those skilled in the art. It should further be appreciated that the methods used to acquire the parameters or their relationship to the tissue types (e.g., using scientific theory, experimentation, computer simulation, etc.) are not a limitation of the present invention. Is should also be appreciated that the term tissue type, as that term is used herein, includes, but is not limited to, blood tissue, plaque tissue (e.g., calcified tissues, fibrous tissues, calcified-necrotic tissues and fibro-lipidic tissues), medial tissue, adventitial tissue, and all other vascular tissues, or combinations thereof (e.g., medial-adventitial tissue), generally known to those skilled in the art. It should also be appreciated that the data storage devices depicted herein (e.g., database 130, memory 150) include, but are not limited to, RAM, cache memory, flash memory, magnetic disks, optical disks, removable disks, SCSI disks, IDE hard drives, tape drives and all other types of data storage devices (and combinations thereof, such as RAID devices) generally known to those skilled in the art.
  • As shown in FIG. 1, the RF data (which is typically in the time domain) is provided to the characterization application 110, where it is converted (or transformed) into the frequency domain. The characterization application 110 is then used to identify a plurality of parameters associated with the transformed RF data (or a portion thereof. The identified parameters are then compared to the parameters stored in the database 130 to identify the corresponding tissue type (or the type of tissue that backscattered the analyzed RF data). Such a process can be used (e.g., once or repeatedly) to identify the portions of RF data (or sets thereof) that are associated with each stored tissue type (e.g., medial, adventitial, plaque, blood, etc.).
  • It should be appreciated that the frequency conversion (or transformation) discussed herein includes, but is not limited to, the use of a fast Fourier transformation (FFT), the Welch periodogram, autoregressive power spectrum (AR) analysis, or any other frequency transformation or spectral analysis generally known to those skilled in the art. It should further be appreciated that the RF data may either be received in real-time (e.g., while the patient is in the operating room) or after a period of delay (e.g., via CD-ROM, etc.). It should also be appreciated that the identified parameters should be related (generally) to the stored parameters. Thus, for example, an estimated Y intercept parameter should be identified if data related to a signal's estimated Y intercept is stored in the database 130 and linked to at least one tissue type.
  • In a second embodiment of the present invention, the characterization application 110 is further used to identify parameters from the RF data (which is typically in the time domain). Parameters associated with the RF data (or a portion thereof can be used, for example, to spatially identify certain frequencies (or parameters related thereto). Thus, for example, if a vascular wall comprises multiple tissue layers, corresponding RF data can be used to identify the location of these tissues and the related frequency spectrum can be used to identify tissue types. The use of parameters to identify tissue types is discussed in detail in U.S. Pat. No. 6,200,268, which was issued on Mar. 13, 2001, and U.S. patent application Ser. No. 10/647,971, which was filed on Aug. 25, 2003, and are incorporated herein, in their entireties, by reference.
  • In either embodiment of the present invention, the RF data (or a transformation thereof and the identified tissue types (including the association therebetween) are provided to the active-contour application 160. This data is then used to identify at least one border on an image of a vascular object (e.g., intra-vascular ultrasound (IVUS) image, Virtual Histology™, (VH) image, etc.). For example, RF data corresponding to blood and plaque tissue can be used to identify (or substantially approximate) the luminal border on a vascular image. Similarly, RF data corresponding to plaque, medial, and/or adventitial tissue can be used to identify (or substantially approximate) the medial-adventitial border on a vascular image.
  • It should be appreciated that the present invention is not limited to the identification of any particular border (or boundary) on a vascular image, and includes all borders generally known to those skilled in the art. It should further be appreciated that the applications depicted and discussed herein (e.g., characterization application 110, gradient-border application 120, frequency-border application 140, active-contour application 160), may exist as a single application or as multiple applications, locally and/or remotely stored. It should also be appreciated that the number and location of the components depicted in FIG. 1 are not intended to limit the present invention, and are merely provided to illustrate the environment in which the present invention may operate. Thus, for example, a computing device having a single data storage device and/or a remotely located characterization application (either in part or in whole) is within the spirit-and scope of the present invention.
  • In another embodiment of the present invention, the computing device 100 further includes a frequency-border application 140. In this embodiment, the characterization application 110 is adapted to provide the RF data (or a transformation thereof and the identified tissue types (including the association therebetween) to the frequency-border application 140, where it is used to determine spectral information. The spectral information is then provided to the active-contour application 160 and used to determine at least one border on a vascular image (i.e., image-border data).
  • In one embodiment of the present invention, the spectral information comprises spectral-force data. Spectral-force data is based (either directly or indirectly) on the information provided by the characterization application 110 and represents a frequency-based force that is applicable to (or a component of the image-border data. The spectral-force data can be used, for example, to determine or refine the image-border data (e.g., as determined by the active-contour application 160). In other words, spectral-force data can be used together with other border-related information to determine a border on a vascular image, or applied to a border determined using border-related information (e.g., as an external force). Thus, the resultant border is based, at least in part, on the spectral-force data.
  • In one embodiment of the present invention, spectral-force data can be analogized to a gravitation field, in which the force (or field) is used to attract a border in a given direction, or to have a given shape. In this embodiment, the strength of the force (or gravitational pull) is directly proportional to the relatedness of the corresponding RF data to a border-related tissue type(s).
  • In another embodiment of the present invention, the spectral information comprises spectral-border data. Spectral-border data is based (either directly or indirectly) on the information provided by the characterization application 110 and represents an estimation of at least one border on a vascular image. The spectral-border data can be used, for example, either alone or together with other border-related information, to determine image-border data (e.g., as determined by the active-contour application 160). It should be appreciated that the term spectral information, as that term is used herein, is not limited to spectral-force data and/or spectral-border data, but further includes any data resulting from a spectral analysis of the acquired RF data.
  • In another embodiment of the present invention, the frequency-border application 140 is further adapted to filter the transformed RF data before it is used to generate spectral information. Specifically, in one embodiment of the present invention, a portion of the vascular object is selected. The corresponding transformed RF data and the information stored in the database 130 are then used to identify the tissue types that are related thereto. The minority tissue type is then filtered out. This can be accomplished, for example, by reassigning the RF data associated with the minority tissue type, so that it is associated with the majority tissue types. For example, if a first portion (or ninety-five percent) of the corresponding RF data is associate with blood tissue and a second portion (or five percent) of the corresponding RF data is associated with plaque tissue, then the second portion would be reassigned so that it is associate with blood tissue (i.e., making a homogenous composition). It should be appreciated, however, that the present invention is not limited to such a filtering algorithm, and includes any other filtering algorithms generally known to those skilled in the art.
  • Referring back to FIG. 1, in one embodiment of the present invention, the computing device 100 further includes a gradient-border application 120. The gradient-border application 120 is adapted to use the acquired RF data to determine gradient information, which can then be used to identify a border or boundary (e.g., used by the gradient-border application 120 to estimate at least one border, provided to the active-contour application and used together with spectral information to determine image-border data, etc.). This is because a change in pixel color (e.g., light-to-dark, dark-to-light, shade1-to-shade2, etc) can indicate the presence of a border.
  • For example, FIG. 2 illustrates an exemplary IVUS image 20 of a vascular object. Starting from the center and working outward, the catheter can be identified by the first light-to-dark transition (or gradient). The catheter border is further identified in FIG. 3 (i.e., 330). Referring back to FIG. 2, and continuing outward, the next dark-to-light transition (or gradient) identifies the luminal border (see FIG. 3, 320). The medial-adventitial border can then be identified by going outward from the luminal border until the next dark-to-light transition (or gradient) is found (see FIG. 3, 310). It should be appreciated that because the IVUS image is constructed using gray-scales, it may be necessary to utilize an algorithm and/or at least one threshold value to identify precisely where the image changes from light to dark (or vice versa). However, it should further be appreciated that the present invention is not limited to any particular algorithm for identifying the aforementioned transitions, and includes all algorithms (and/or threshold values) generally known to those skilled in the art.
  • In another embodiment of the present invention, the gradient-border application 120 is further adapted to process the acquired RF data using traditional IVUS imaging techniques. For example, the gradient-border application 120 may be adapted to filter the RF data (e.g., using a highpass filter, etc.), detect relevant portions (e.g., envelope detection, etc.), and/or modulate any portion thereof (e.g., smoothing, log compressing, etc.). Such techniques are all well known to those skilled in the art. The resultant data can then be used to produce an IVUS image or determine gradient information.
  • In one embodiment of the present invention, the gradient information comprises gradient-force data. Gradient-force data is based (either directly or indirectly) on the gradients in an IVUS image and represents a gradient-based force that is applicable to (or a component on the image-border data. The gradient-force data can be used, for example, to determine or refine the image-border data (e.g., as determined by the active-contour application 160). In other words, gradient-force data can be used together with other border-related information to determine a border on a vascular image, or applied to a border determined using border-related information (e.g., as an external force). Thus, the resultant border is based, at least in part, on the gradient-force data.
  • In one embodiment of the present invention, gradient-force data can be analogized to a gravitation field, in which the force (or field) is used to attract a border in a given direction, or to have a given shape. In this embodiment, the strength of the force (or gravitational pull), is directly proportional to the gradients in the IVUS image (or transitions therein).
  • In another embodiment of the present invention, the gradient information comprises gradient-border data. Gradient-border data is based (either directly or indirectly) on the gradients in an IVUS image and represents an estimation of at least one border on a vascular image (e.g., the IVUS image, a VH image, etc.). The gradient-border data can be used, for example, either alone or together with other border-related information (e.g., spectral information, etc.), to determine at least one border on a vascular image. It should be appreciated that the term gradient information, as that term is used herein, is not limited to gradient-force data and/or gradient-border data, but further includes any data resulting from an analysis of the gradients in an IVUS image.
  • In another embodiment of the present invention, the active-contour application 160 is further adapted to use other-border information to determine a border on a vascular image. In other words, information related to a border on another image(s) (e.g., a previous image, a subsequent image, multiple images, etc.) is used to determine (or approximate) at least one border on the vascular image at issue (i.e., the current vascular image).
  • For example, in one embodiment of the present invention, the border-detection algorithm 160 is adapted to identify at least one control point on the border of another image. With reference to FIGS. 3 and 4, the border-detection algorithm can be used, for example, to identify a plurality of control points 22 on the luminal border 320. It should be appreciated that the location and number of control points depicted in FIG. 4 are not intended to limit the present invention, and are merely provided to illustrate the environment in which the present invention may operate. In an alternate embodiment, the active-contour application 160 is adapted to identify a border using user-identified control points. Such an embodiment is discussed in detail in U.S. Pat. No. 6,381,350, which was issued on Apr. 30, 2002, and is incorporated herein, in its entirety, by reference.
  • With reference to FIG. 1, once the border and control points are identified on another image, the active-contour application 160 can be used to identify at least one control point on the current vascular image. In one embodiment of the present invention, this is done by extrapolating the previously identified control points to the current vascular image. By doing this, multiple 2D images (or at least one 3D image) can be produced. For example, as illustrated in FIG. 5, multiple 2D images (e.g., 20, 52 a-52 d, etc.) are used to produce a 3D image of a tubular (e.g., vascular) object 50. It should be appreciated that a memory device 150 (see FIG. 1) can be used to store information related to this embodiment (e.g., a border on another image, control points on such a border, extrapolated control points, resulting image-border data, etc.).
  • FIG. 6 illustrates one method as to how an identified control point can be extrapolated to the current vascular image. Specifically, the control points that were illustrated in FIG. 4 (i.e., 22) are extrapolated (or copied) to the current image (e.g., 52 d), thus creating a second set of control points 62. In one embodiment of the present invention, the control points are extrapolated using Cartesian coordinates. It should be appreciated that, while FIG. 6 illustrates control points being extrapolated to an adjacent image, the present invention is not so limited. Thus, extracting control points to (or from) additional images (e.g., 52 c, 52 b, etc.) is within the spirit and scope of the present invention.
  • Once the control points are extrapolated, the active-contour application 160 is further adapted to identify (or approximate) a border based on the extrapolated points. For example, as shown in FIG. 6, the extrapolated points 62 may be connected using a plurality of lines 64, where the lines are either straight or curved (not shown). In another embodiment of the present invention, the extrapolating application is adapted to use an algorithm (e.g., a cubic-interpolation algorithm, etc.) to identify line shape. Border extrapolation is discussed in detail in U.S. patent application Ser. No. 10/647,473, which was filed Aug. 26, 2003, and is incorporated herein, in its entirety, by reference.
  • Referring back to FIG. 1, the active-contour application 160 is then used to adjust the border to more closely match the actual border of the vascular object. In doing so, the active-contour application 160 may consider, or take into account, at least (i) the proximity of the border to each extrapolated point (i.e., continuity or control-point factor), (ii) border curvature or smoothness (i.e., curvature or boundary factor), and/or (iii) the relationship between multiple borders (i.e., relatedness factor). For example, by considering a continuity or control-point factor, the border can be adjusted so that it passes through each extrapolated point. By considering a curvature or boundary factor, the border can be adjusted to prevent sharp transitions (e.g., corners, etc.). Furthermore, by considering a relatedness factor, multiple borders can be adjusted in relation to one another (e.g., the luminal border can always be located inside the medial-adventitial border, etc.).
  • In one embodiment of the present invention, these three factors are also used to determine related borders on adjacent images. It should be appreciated that if multiple factors are being considered, then individual factors may be weighted more heavily than others. This becomes important if the factors produce different results. It should further be appreciated that the present invention is not limited to the use of the aforementioned factors for border optimization, and that the use of additional factors to adjust (or optimize) a border is within the spirit and scope of the present invention.
  • In one embodiment of the present invention, the adjusted borders are configured to be manually manipulated. In other words, at least one point on the border can be selected and manually moved to a new location. The active-contour application 160 is then used (as previously discussed) to reconstruct the border accordingly. In another embodiment of the present invention, the active-contour application is further adapted to adjust related borders in adjacent images. This is done by fitting a geometrical model (e.g., a tensor product B-spline, etc.) over the surface of a plurality of related borders (e.g., as identified on multiple IVUS images). A plurality of points on the geometrical model are then parameterized and formulated into a constrained least-squares system of equations. If a point on the border is manually moved, the active-contour application can utilize these equations to calculate a resulting surface (or mesh of control points). The affected borders (e.g., adjacent borders) can then be adjusted accordingly.
  • Once the border has been sufficiently adjusted, the aforementioned process can be repeated to identify additional borders. In an alternate embodiment of the present invention, multiple borders (e.g., luminal and medial-adventitial borders) are identified concurrently. In other words, the active-contour application 160, for example, can either be used (e.g., initiated) to identify a single border on a vascular image, thus requiring a subsequent use to identify another border on the vascular image, or used (e.g., initiated) to identify multiple borders on a vascular image. In the latter, the multiple borders are identified at substantially the same time. The multiple borders can then be imaged (in either 2D or 3D) and analyzed by either a skilled practitioner or a computer algorithm. For example, as illustrated in FIG. 7, the luminal border 74 and the medial-adventitial border 76 can be used (by either a clinician or an algorithm) to identify the plaque-media complex 78 of a vascular object.
  • One method of identifying a border on a vascular image is illustrated in FIG. 8. Specifically, at step 800, RF data backscattered from vascular tissue is acquired. The RF data is then (i) transformed from the time domain into the frequency domain and (ii) processed using traditional IVUS imaging techniques, at steps 810 and 820, respectively. With respect to the transformed RF data, a plurality of parameters are identified at step 812, and compared to stored parameters, at step 814, to identify a plurality of tissue types. At step 816; RF data (or a transformation thereof) that corresponds to at least relevant (e.g., border-related) tissue types is identified. The corresponding RF data is then used to determine spectral information (e.g., spectral-force data, spectral-border data, etc.) at step 818.
  • With respect to the IVUS data, gradients are used to determine gradient information (e.g., gradient-force data, gradient-border data, etc.) at step 822. At step 824, other-border data (e.g., data related to at least one border on at least one other image) is used to approximate at least one border on the current vascular image. At step 826, the gradient information and spectral information are used to modify the at least one border on the current vascular image, ending the method at step 828. It should be appreciated that the present invention is not limited to the method illustrated in FIG. 8, and further includes all methods of operation generally described or suggested herein or discernable by one skilled in art. For example, a method that uses only spectral information to determine at least one border on a vascular image is within the spirit and scope of the present invention.
  • Having thus described preferred embodiments of a system and method of identifying a border on a vascular image, it should be apparent to those skilled in the art that certain advantages of the system have been achieved. It should also be appreciated that various modifications, adaptations, and alternative embodiments thereof may be made within the scope and spirit of the present invention. The invention is further defined by the following claims.

Claims (27)

1. A method of identifying a border on an image of a vascular object, comprising:
acquiring RF data backscattered from vascular tissue;
transforming said RF data into the frequency domain;
identifying a plurality of parameters of said transformed RF data;
using said plurality of parameters and previously stored data to identify at least a first and second portion of said transformed RF data that corresponds to a blood and non-blood portion of said vascular tissue, respectively; and
determining said border on said image of said vascular object in accordance with said first and second portions of said transformed RF data.
2. The method of claim 1, wherein said second portion of said vascular tissue corresponds to a plaque portion of said vascular tissue.
3. The method of claim 1, wherein said step of determining said border further comprises determining the luminal border on said image of said vascular object in accordance with said first and second portions of said transformed RF data.
4. The method of claim 3, wherein said steps of (i) using said plurality of parameters and previously stored data to identify a least a first and second portion of said transformed RF data and (ii) determining said border further comprises:
using said plurality of parameters and previously stored data to identify at least a third portion of said transformed RF data that corresponds to at least a third tissue type of said vascular tissue, said third tissue type being selected from a list of tissue types consisting of medial tissue and adventitial tissue; and
determining the medial-adventitial border on said image of said vascular object in accordance with said second and third portion of said transformed RF data.
5. The method of claim 4, wherein said third tissue type corresponds to both medial and adventitial tissues.
6. The method of claim 1, wherein said step of determining said border further comprises determining said border on said image of said vascular object in accordance with gradient information, said gradient information being derived from said RF data.
7. The method of claim 1, further comprising the step of using other-border data from at least one other image of said vascular object to approximate said border on said image of said vascular object.
8. The method of claim 7, wherein said step of determining said border further comprises determining said border on said image of said vascular object in accordance with gradient information, said gradient information being derived from said RF data.
9. The method of claim 6, wherein said gradient information further comprises gradient-force data and gradient-border data.
10. The method of claim 1, further comprising the step of filtering said first and second portions of said transformed RF data before they are used to determine said border.
11. The method of claim 10, wherein said step of filtering further comprises filtering said second portion of said transformed RF data to reduce the amount of non-blood particles visible in an image of said second portion of said transformed RF data.
12. The method of claim 11, wherein said step of filtering further comprises filtering said first portion of said transformed RF data to reduce the number of tissue types visible in an image of said first portion of said transformed RF data.
13. The method of claim 1, wherein said step of determining said border further comprises determining said border on said image of said vascular object in accordance with spectral-force data and spectral-border data, said spectral-force data and said spectral-border data being derived from said transformed RF data.
14. The method of claim 1, wherein said step of determining said border further comprises determining said border on said image of said vascular object in accordance with at least one algorithm, said at least one algorithm being selected from a list of algorithms consisting of a continuity algorithm, a curvature algorithm, and a relatedness algorithm.
15. The method of claim 1, wherein said step of transforming said RF data further comprises transforming said RF data into the autoregressive (AR) frequency power spectrum.
16. The method of claim 1, wherein said step of identifying a plurality of parameters further comprises identifying at least one parameter of said transformed RF data, said at least one parameter being selected from a list of parameters consisting of maximum power, minimum power, frequency at maximum power, frequency at minimum power, y intercept, slope, mid-band fit, and integrated backscatter.
17. The method of claim 1, wherein said step of acquiring RF data further comprises acquiring RF data that is both backscattered from said vascular tissue and gated to electrocardiogram (ECG) information.
18. The method of claim 1, wherein said step of identifying a plurality of parameters of said transformed RF data further comprises identifying at least one parameter of said RF data.
19. The method of claim 18, wherein said at least one parameter of said RF data comprises tissue depth.
20. A method of identifying at least one boundary on a vascular image, comprising:
acquiring RF data backscattered from vascular tissue;
transforming said RF data into the frequency domain;
identifying at least one parameter of said transformed RF data;
using said at least one parameter and previously stored data to identify at least one tissue type and transformed RF data corresponding thereto (corresponding RF data);
using said RF data to determine gradient information pertaining to said at least one boundary on said vascular image; and
using at least said gradient information and said corresponding RF data to determine said at least one boundary on said vascular image.
21. The method of claim 20, wherein said step of using at least said gradient information and said corresponding RF data further comprises using at least said gradient information and said transformed RF data to determine said at least one boundary on said vascular image.
22. The method of claim 20, wherein said at least one parameter is selected from a list of parameters consisting of maximum power, minimum power, frequency at maximum power, frequency at minimum power, y intercept, slope, mid-band fit, and integrated backscatter.
23. The method of claim 20, wherein said step of using said gradient information and said corresponding RF data further comprises using other-boundary data to determine said at least one boundary on said vascular image.
24. The method of claim 23, further comprising the step of using said corresponding. RF data to determine spectral-force data and spectral-boundary data, wherein at least said spectral-force data, said spectral-boundary data, and said gradient information are used to determine said at least one boundary on said vascular image.
25. The method of claim 23, further comprising the step of using said gradient information to determine gradient-force data and gradient-border data, wherein at least said gradient-force data, said gradient-boundary data and corresponding RF data are used to determine said at least one boundary on said vascular image.
26. The method of claim 24, further comprising the step of using said gradient information to determine gradient-force data and gradient-border data, wherein at least said gradient-force data, said spectral-force data, said gradient-border data, and said spectral-border data are used to determine said at least one boundary on said vascular image.
27. The method of claim 24, further comprising the step of filtering said corresponding RF data before it is used to determine said spectral-force data and said spectral-boundary data.
US11/786,599 2004-03-04 2007-04-12 System and method for vascular border detection Abandoned US20070201736A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/786,599 US20070201736A1 (en) 2004-03-04 2007-04-12 System and method for vascular border detection

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55062004P 2004-03-04 2004-03-04
US10/837,352 US7215802B2 (en) 2004-03-04 2004-04-29 System and method for vascular border detection
US11/786,599 US20070201736A1 (en) 2004-03-04 2007-04-12 System and method for vascular border detection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/837,352 Continuation US7215802B2 (en) 2004-03-04 2004-04-29 System and method for vascular border detection

Publications (1)

Publication Number Publication Date
US20070201736A1 true US20070201736A1 (en) 2007-08-30

Family

ID=34915696

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/837,352 Active 2025-06-07 US7215802B2 (en) 2004-03-04 2004-04-29 System and method for vascular border detection
US11/449,569 Active 2024-05-23 US7463759B2 (en) 2004-03-04 2006-06-08 System and method for vascular border detection
US11/786,599 Abandoned US20070201736A1 (en) 2004-03-04 2007-04-12 System and method for vascular border detection

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/837,352 Active 2025-06-07 US7215802B2 (en) 2004-03-04 2004-04-29 System and method for vascular border detection
US11/449,569 Active 2024-05-23 US7463759B2 (en) 2004-03-04 2006-06-08 System and method for vascular border detection

Country Status (6)

Country Link
US (3) US7215802B2 (en)
EP (1) EP1732461B1 (en)
JP (1) JP4733107B2 (en)
AT (1) ATE504239T1 (en)
DE (1) DE602005027334D1 (en)
WO (1) WO2005091885A2 (en)

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070127756A1 (en) * 2005-12-07 2007-06-07 Siemens Corporate Research, Inc. Method and Apparatus for Ear Canal Surface Modeling Using Optical Coherence Tomography Imaging
US20120275672A1 (en) * 2006-05-22 2012-11-01 Upmc System and Method for Improved Viewing and Navigation of Digital Images
US20140100440A1 (en) * 2012-10-05 2014-04-10 Volcano Corporation System and method for instant and automatic border detection
WO2014055923A3 (en) * 2012-10-05 2015-07-23 Elizabeth Begin System and method for instant and automatic border detection
US9286673B2 (en) 2012-10-05 2016-03-15 Volcano Corporation Systems for correcting distortions in a medical image and methods of use thereof
US9292918B2 (en) 2012-10-05 2016-03-22 Volcano Corporation Methods and systems for transforming luminal images
US9301687B2 (en) 2013-03-13 2016-04-05 Volcano Corporation System and method for OCT depth calibration
US9307926B2 (en) 2012-10-05 2016-04-12 Volcano Corporation Automatic stent detection
US9324141B2 (en) 2012-10-05 2016-04-26 Volcano Corporation Removal of A-scan streaking artifact
US9360630B2 (en) 2011-08-31 2016-06-07 Volcano Corporation Optical-electrical rotary joint and methods of use
US9367965B2 (en) 2012-10-05 2016-06-14 Volcano Corporation Systems and methods for generating images of tissue
US9383263B2 (en) 2012-12-21 2016-07-05 Volcano Corporation Systems and methods for narrowing a wavelength emission of light
US9478940B2 (en) 2012-10-05 2016-10-25 Volcano Corporation Systems and methods for amplifying light
US9486143B2 (en) 2012-12-21 2016-11-08 Volcano Corporation Intravascular forward imaging device
US9596993B2 (en) 2007-07-12 2017-03-21 Volcano Corporation Automatic calibration systems and methods of use
US9612105B2 (en) 2012-12-21 2017-04-04 Volcano Corporation Polarization sensitive optical coherence tomography system
US20170103498A1 (en) * 2015-10-08 2017-04-13 Acist Medical Systems, Inc. Systems and methods to reduce near-field artifacts
US9622706B2 (en) 2007-07-12 2017-04-18 Volcano Corporation Catheter for in vivo imaging
US9709379B2 (en) 2012-12-20 2017-07-18 Volcano Corporation Optical coherence tomography system that is reconfigurable between different imaging modes
US9730613B2 (en) 2012-12-20 2017-08-15 Volcano Corporation Locating intravascular images
US9770172B2 (en) 2013-03-07 2017-09-26 Volcano Corporation Multimodal segmentation in intravascular images
US20170330331A1 (en) 2016-05-16 2017-11-16 Acist Medical Systems, Inc. Motion-based image segmentation systems and methods
US9858668B2 (en) 2012-10-05 2018-01-02 Volcano Corporation Guidewire artifact removal in images
US9867530B2 (en) 2006-08-14 2018-01-16 Volcano Corporation Telescopic side port catheter device with imaging system and method for accessing side branch occlusions
US10058284B2 (en) 2012-12-21 2018-08-28 Volcano Corporation Simultaneous imaging, monitoring, and therapy
US10070827B2 (en) 2012-10-05 2018-09-11 Volcano Corporation Automatic image playback
US10166003B2 (en) 2012-12-21 2019-01-01 Volcano Corporation Ultrasound imaging with variable line density
US10191220B2 (en) 2012-12-21 2019-01-29 Volcano Corporation Power-efficient optical circuit
US10219887B2 (en) 2013-03-14 2019-03-05 Volcano Corporation Filters with echogenic characteristics
US10219780B2 (en) 2007-07-12 2019-03-05 Volcano Corporation OCT-IVUS catheter for concurrent luminal imaging
US10226597B2 (en) 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
US10238367B2 (en) 2012-12-13 2019-03-26 Volcano Corporation Devices, systems, and methods for targeted cannulation
US10292677B2 (en) 2013-03-14 2019-05-21 Volcano Corporation Endoluminal filter having enhanced echogenic properties
US10332228B2 (en) 2012-12-21 2019-06-25 Volcano Corporation System and method for graphical processing of medical data
US10413317B2 (en) 2012-12-21 2019-09-17 Volcano Corporation System and method for catheter steering and operation
CN110246136A (en) * 2019-05-29 2019-09-17 山东大学 A kind of intravascular ultrasound parameter extracting method and system based on hybrid algorithm
US10420530B2 (en) 2012-12-21 2019-09-24 Volcano Corporation System and method for multipath processing of image signals
US10426590B2 (en) 2013-03-14 2019-10-01 Volcano Corporation Filters with echogenic characteristics
US10568586B2 (en) 2012-10-05 2020-02-25 Volcano Corporation Systems for indicating parameters in an imaging data set and methods of use
US10595820B2 (en) 2012-12-20 2020-03-24 Philips Image Guided Therapy Corporation Smooth transition catheters
US10638939B2 (en) 2013-03-12 2020-05-05 Philips Image Guided Therapy Corporation Systems and methods for diagnosing coronary microvascular disease
US10653393B2 (en) 2015-10-08 2020-05-19 Acist Medical Systems, Inc. Intravascular ultrasound imaging with frequency selective imaging methods and systems
US10724082B2 (en) 2012-10-22 2020-07-28 Bio-Rad Laboratories, Inc. Methods for analyzing DNA
US10758207B2 (en) 2013-03-13 2020-09-01 Philips Image Guided Therapy Corporation Systems and methods for producing an image from a rotational intravascular ultrasound device
US10942022B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Manual calibration of imaging system
US10939826B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Aspirating and removing biological material
US10987086B2 (en) 2009-10-12 2021-04-27 Acist Medical Systems, Inc. Intravascular ultrasound system for co-registered imaging
US10993694B2 (en) 2012-12-21 2021-05-04 Philips Image Guided Therapy Corporation Rotational ultrasound imaging catheter with extended catheter body telescope
US11024034B2 (en) 2019-07-02 2021-06-01 Acist Medical Systems, Inc. Image segmentation confidence determination
US11026591B2 (en) 2013-03-13 2021-06-08 Philips Image Guided Therapy Corporation Intravascular pressure sensor calibration
US11040140B2 (en) 2010-12-31 2021-06-22 Philips Image Guided Therapy Corporation Deep vein thrombosis therapeutic methods
US11141063B2 (en) 2010-12-23 2021-10-12 Philips Image Guided Therapy Corporation Integrated system architectures and methods of use
US11154313B2 (en) 2013-03-12 2021-10-26 The Volcano Corporation Vibrating guidewire torquer and methods of use
US11369337B2 (en) 2015-12-11 2022-06-28 Acist Medical Systems, Inc. Detection of disturbed blood flow
US11406498B2 (en) 2012-12-20 2022-08-09 Philips Image Guided Therapy Corporation Implant delivery system and implants

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727153B2 (en) * 2003-04-07 2010-06-01 Sonosite, Inc. Ultrasonic blood vessel measurement apparatus and method
CN1846231A (en) * 2003-07-21 2006-10-11 派昂公司 Method and system for identifying optimal image within a series of images that depict a moving organ
US7224356B2 (en) * 2004-06-08 2007-05-29 Microsoft Corporation Stretch-driven mesh parameterization using spectral analysis
EP1615170A1 (en) * 2004-07-10 2006-01-11 Evotec Technologies GmbH Image segmentation algorithms for applications in cellular biology
JP4575737B2 (en) * 2004-09-29 2010-11-04 富士フイルム株式会社 Ultrasonic imaging device
JP4585326B2 (en) * 2005-02-08 2010-11-24 富士フイルム株式会社 Ultrasonic imaging apparatus and ultrasonic imaging method
KR100856042B1 (en) * 2005-10-07 2008-09-03 주식회사 메디슨 Ultrasound imaging system for extracting volume of object from ultrasound image and method for the same
US7988633B2 (en) 2005-10-12 2011-08-02 Volcano Corporation Apparatus and method for use of RFID catheter intelligence
US20070160275A1 (en) * 2006-01-11 2007-07-12 Shashidhar Sathyanarayana Medical image retrieval
CN107260126B (en) * 2007-01-19 2021-07-13 桑尼布鲁克健康科学中心 Imaging probe with combined ultrasound and optical imaging means
US11064964B2 (en) 2007-03-08 2021-07-20 Sync-Rx, Ltd Determining a characteristic of a lumen by measuring velocity of a contrast agent
JP5639764B2 (en) 2007-03-08 2014-12-10 シンク−アールエックス,リミティド Imaging and tools for use with moving organs
US8781193B2 (en) 2007-03-08 2014-07-15 Sync-Rx, Ltd. Automatic quantitative vessel analysis
WO2014002095A2 (en) 2012-06-26 2014-01-03 Sync-Rx, Ltd. Flow-related image processing in luminal organs
US9968256B2 (en) 2007-03-08 2018-05-15 Sync-Rx Ltd. Automatic identification of a tool
US10716528B2 (en) 2007-03-08 2020-07-21 Sync-Rx, Ltd. Automatic display of previously-acquired endoluminal images
US9375164B2 (en) 2007-03-08 2016-06-28 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
US11197651B2 (en) 2007-03-08 2021-12-14 Sync-Rx, Ltd. Identification and presentation of device-to-vessel relative motion
WO2012176191A1 (en) 2011-06-23 2012-12-27 Sync-Rx, Ltd. Luminal background cleaning
US9629571B2 (en) 2007-03-08 2017-04-25 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
WO2009143163A2 (en) * 2008-05-21 2009-11-26 University Of Florida Research Foundation, Inc. Face relighting from a single image
ES2450391T3 (en) 2008-06-19 2014-03-24 Sync-Rx, Ltd. Progressive progress of a medical instrument
US9974509B2 (en) 2008-11-18 2018-05-22 Sync-Rx Ltd. Image super enhancement
US9095313B2 (en) 2008-11-18 2015-08-04 Sync-Rx, Ltd. Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe
US9144394B2 (en) 2008-11-18 2015-09-29 Sync-Rx, Ltd. Apparatus and methods for determining a plurality of local calibration factors for an image
US9101286B2 (en) 2008-11-18 2015-08-11 Sync-Rx, Ltd. Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points
US10362962B2 (en) 2008-11-18 2019-07-30 Synx-Rx, Ltd. Accounting for skipped imaging locations during movement of an endoluminal imaging probe
US8855744B2 (en) 2008-11-18 2014-10-07 Sync-Rx, Ltd. Displaying a device within an endoluminal image stack
US11064903B2 (en) 2008-11-18 2021-07-20 Sync-Rx, Ltd Apparatus and methods for mapping a sequence of images to a roadmap image
US8478012B2 (en) * 2009-09-14 2013-07-02 General Electric Company Methods, apparatus and articles of manufacture to process cardiac images to detect heart motion abnormalities
US9138147B2 (en) * 2009-09-23 2015-09-22 Lightlab Imaging, Inc. Lumen morphology image reconstruction based on the scan line data of OCT
US8961420B2 (en) 2010-04-01 2015-02-24 Siemens Medical Solutions Usa, Inc. System for cardiac condition detection and characterization
CN101964118B (en) * 2010-09-30 2012-09-19 华北电力大学(保定) Three-dimensional segmentation method for intravascular ultrasound image sequence
US20120220867A1 (en) 2010-12-31 2012-08-30 Volcano Corporation Pulmonary Embolism Therapeutic Methods Using Therapeutic Cutting Devices and Systems
US9295447B2 (en) * 2011-08-17 2016-03-29 Volcano Corporation Systems and methods for identifying vascular borders
CA3194212A1 (en) * 2011-10-14 2013-04-18 Jointvue, Llc Real-time 3-d ultrasound reconstruction of knee and its implications for patient specific implants and 3-d joint injections
CA2866509A1 (en) * 2011-12-21 2013-06-27 Volcano Corporation Method for visualizing blood and blood-likelihood in vascular images
EP2628449B1 (en) * 2012-02-17 2020-05-20 Samsung Electronics Co., Ltd. Ultrasound apparatus and method of generating ultrasound image
US10398413B2 (en) 2012-12-21 2019-09-03 Volcano Corporation Method for multi-frequency imaging and composite image display using high-bandwidth transducer outputs
US10799209B2 (en) 2012-12-26 2020-10-13 Philips Image Guided Therapy Corporation Measurement navigation in a multi-modality medical imaging system
US10642953B2 (en) 2012-12-26 2020-05-05 Philips Image Guided Therapy Corporation Data labeling and indexing in a multi-modality medical imaging system
US10368836B2 (en) * 2012-12-26 2019-08-06 Volcano Corporation Gesture-based interface for a multi-modality medical imaging system
US9592027B2 (en) * 2013-03-14 2017-03-14 Volcano Corporation System and method of adventitial tissue characterization
JP2016514031A (en) * 2013-03-14 2016-05-19 ボルケーノ コーポレイション Parallel tree-based pattern recognition for organizational characterization
US10716536B2 (en) 2013-07-17 2020-07-21 Tissue Differentiation Intelligence, Llc Identifying anatomical structures
US10154826B2 (en) 2013-07-17 2018-12-18 Tissue Differentiation Intelligence, Llc Device and method for identifying anatomical structures
US10874409B2 (en) 2014-01-14 2020-12-29 Philips Image Guided Therapy Corporation Methods and systems for clearing thrombus from a vascular access site
JP6389526B2 (en) 2014-01-14 2018-09-12 ボルケーノ コーポレイション System and method for assessing hemodialysis arteriovenous fistula maturation
CN105916457A (en) * 2014-01-14 2016-08-31 火山公司 Devices and methods for forming vascular access
US11260160B2 (en) 2014-01-14 2022-03-01 Philips Image Guided Therapy Corporation Systems and methods for improving an AV access site
WO2015108942A1 (en) * 2014-01-14 2015-07-23 Volcano Corporation Vascular access evaluation and treatment
EP3166479B1 (en) 2014-07-11 2024-01-03 Koninklijke Philips N.V. Devices and systems for treatment of vessels
WO2016092390A1 (en) 2014-12-08 2016-06-16 Koninklijke Philips N.V. Interactive physiologic data and intravascular imaging data and associated devices, systems, and methods
EP4230121A3 (en) 2014-12-10 2023-11-08 Koninklijke Philips N.V. Systems for in-stent restenosis prediction
CN107530049B (en) 2015-02-20 2021-06-04 皇家飞利浦有限公司 Atherectomy device with imaging support
EP3314603A1 (en) 2015-06-25 2018-05-02 Koninklijke Philips N.V. Interactive intravascular procedure training and associated devices, systems, and methods
JP6516597B2 (en) * 2015-07-07 2019-05-22 キヤノン株式会社 Image processing apparatus and image processing method
WO2017046628A1 (en) 2015-09-15 2017-03-23 Koninklijke Philips N.V. Device and method for using ivus data to characterize and evaluate a vascular graft condition
KR101937018B1 (en) * 2016-03-24 2019-01-09 울산대학교 산학협력단 Method and device for automatic inner and outer vessel wall segmentation in intravascular ultrasound images using deep learning
US11701086B1 (en) 2016-06-21 2023-07-18 Tissue Differentiation Intelligence, Llc Methods and systems for improved nerve detection
US11819360B2 (en) 2017-08-15 2023-11-21 Koninklijke Philips N.V. Intraluminal rotational ultrasound for diagnostic imaging and therapy
US11883235B2 (en) 2017-08-15 2024-01-30 Philips Image Guided Therapy Corporation Phased array imaging and therapy intraluminal ultrasound device
CN111065342B (en) 2017-08-15 2023-07-04 皇家飞利浦有限公司 Intracavity ultrasound device for diagnostic imaging and therapy
WO2019034687A1 (en) 2017-08-15 2019-02-21 Koninklijke Philips N.V. Intracardiac therapeutic and diagnostic ultrasound device
CN111212606B (en) 2017-08-15 2024-03-01 皇家飞利浦有限公司 Frequency tunable intravascular ultrasound device
WO2019034689A1 (en) 2017-08-16 2019-02-21 Koninklijke Philips N.V. Disposable therapeutic ultrasound device
WO2019174971A1 (en) 2018-03-14 2019-09-19 Koninklijke Philips N.V. Alternative anatomical borders of blood vessels and associated devices, systems, and methods
WO2019210124A1 (en) * 2018-04-26 2019-10-31 University Of Louisville Research Foundation, Inc. Atlas for segmentation of retina layers from oct images
US11596384B2 (en) 2018-10-26 2023-03-07 Philips Image Guided Therapy Corporation Intraluminal ultrasound vessel border selection and associated devices, systems, and methods
WO2020084028A1 (en) 2018-10-26 2020-04-30 Koninklijke Philips N.V. Intraluminal ultrasound imaging with automatic and assisted labels and bookmarks
US20200129158A1 (en) 2018-10-26 2020-04-30 Volcano Corporation Graphical longitudinal display for intraluminal ultrasound imaging and associated devices, systems, and methods
EP3870069B1 (en) 2018-10-26 2023-09-20 Koninklijke Philips N.V. Intraluminal ultrasound directional guidance and associated devices and systems
EP4272654A3 (en) 2018-10-26 2024-04-03 Koninklijke Philips N.V. Speed determination for intraluminal ultrasound imaging and associated devices, systems, and methods
CN112912011A (en) 2018-10-26 2021-06-04 皇家飞利浦有限公司 Intraluminal ultrasound navigation guidance and associated devices, systems, and methods
CN110051385B (en) * 2019-05-29 2023-01-24 深圳华声医疗技术股份有限公司 Full-automatic measurement method, device, storage medium and system based on blood vessel identification
WO2021069216A1 (en) * 2019-10-10 2021-04-15 Koninklijke Philips N.V. Vascular tissue characterization devices, systems, and methods
WO2021089810A1 (en) 2019-11-06 2021-05-14 Philips Image Guided Therapy Corporation Co-registration of intravascular data and multi-segment vasculature, and associated devices, systems, and methods
CN114901154A (en) 2019-12-10 2022-08-12 皇家飞利浦有限公司 Intravascular image based vessel diameter determination and associated devices, systems, and methods
WO2021140042A1 (en) 2020-01-06 2021-07-15 Koninklijke Philips N.V. Intraluminal imaging based detection and visualization of intraluminal treatment anomalies
CN115397335A (en) 2020-03-10 2022-11-25 皇家飞利浦有限公司 Intraluminal image visualization with adaptive scaling and related systems, methods, and devices
WO2023052278A1 (en) 2021-09-30 2023-04-06 Koninklijke Philips N.V. Intraluminal ultrasound vessel segment identification and associated devices, systems, and methods
US20230181140A1 (en) 2021-12-11 2023-06-15 Philips Image Guided Therapy Corporation Registration of intraluminal physiological data to longitudinal image body lumen using extraluminal imaging data
US20230190227A1 (en) 2021-12-16 2023-06-22 Philips Image Guided Therapy Corporation Plaque burden indication on longitudinal intraluminal image and x-ray image
WO2023110594A1 (en) 2021-12-17 2023-06-22 Philips Image Guided Therapy Corporation Intravascular imaging assessment of stent deployment and associated systems, devices, and methods
WO2023110555A1 (en) 2021-12-17 2023-06-22 Koninklijke Philips N.V. Systems, devices, and methods for coregistration of intravascular data to enhanced stent deployment x-ray images
WO2023110607A1 (en) 2021-12-17 2023-06-22 Koninklijke Philips N.V. Control of laser atherectomy by co-registered intravascular imaging
US20230190215A1 (en) 2021-12-22 2023-06-22 Philips Image Guided Therapy Corporation Co-registration of intraluminal data to no contrast x-ray image frame and associated systems, device and methods
WO2023118080A1 (en) 2021-12-22 2023-06-29 Koninklijke Philips N.V. Intravascular ultrasound imaging for calcium detection and analysis
EP4201342A1 (en) 2021-12-22 2023-06-28 Koninklijke Philips N.V. Intravascular ultrasound imaging for calcium detection and analysis
WO2023169967A1 (en) 2022-03-08 2023-09-14 Koninklijke Philips N.V. Intravascular ultrasound imaging with contour generation and editing for circular and non-circular blood vessel borders
WO2023247467A1 (en) 2022-06-24 2023-12-28 Koninklijke Philips N.V. Intraluminal ultrasound imaging with automatic detection of target and reference regions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478219A (en) * 1982-03-24 1984-10-23 Manuel Dujovny Temporary microvascular occluder
US5657760A (en) * 1994-05-03 1997-08-19 Board Of Regents, The University Of Texas System Apparatus and method for noninvasive doppler ultrasound-guided real-time control of tissue damage in thermal therapy
US6475149B1 (en) * 2001-09-21 2002-11-05 Acuson Corporation Border detection method and system
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US20050027188A1 (en) * 2002-12-13 2005-02-03 Metaxas Dimitris N. Method and apparatus for automatically detecting breast lesions and tumors in images
US7070595B2 (en) * 1998-12-14 2006-07-04 Medwaves, Inc. Radio-frequency based catheter system and method for ablating biological tissues

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228804A (en) * 1978-02-28 1980-10-21 Case Western Reserve University Diagnostic ultrasonography utilizing frequency spectrum analysis presented in terms of B-scan color patterns or X-Y graph displays
JPS5849140A (en) * 1981-09-19 1983-03-23 株式会社東芝 Ultrasonic diagnostic apparatus
US4575799A (en) * 1983-03-23 1986-03-11 Fujitsu Limited Ultrasonic living body tissue characterization system
US4561019A (en) * 1983-05-16 1985-12-24 Riverside Research Institute Frequency diversity for image enhancement
US4858124A (en) * 1984-08-15 1989-08-15 Riverside Research Institute Method for enhancement of ultrasonic image data
US5445155A (en) * 1991-03-13 1995-08-29 Scimed Life Systems Incorporated Intravascular imaging apparatus and methods for use and manufacture
US5235984A (en) * 1992-03-30 1993-08-17 Hewlett-Packard Company On-line acoustic densitometry tool for use with an ultrasonic imaging system
JPH05337111A (en) * 1992-06-10 1993-12-21 Nippon Koden Corp Ultrasonic diagnostic apparatus
GB2291969A (en) * 1993-04-19 1996-02-07 Commw Scient Ind Res Org Tissue characterisation using intravascular echoscopy
DE69429743T2 (en) * 1993-06-29 2002-10-02 Koninkl Philips Electronics Nv Method and device for determining a contour in a room characterized by a density distribution
US5363850A (en) * 1994-01-26 1994-11-15 Cardiovascular Imaging Systems, Inc. Method for recognition and reduction of blood speckle in blood vessel imaging system
US5417215A (en) * 1994-02-04 1995-05-23 Long Island Jewish Medical Center Method of tissue characterization by ultrasound
US5724972A (en) * 1996-05-02 1998-03-10 Acuson Corporation Method and apparatus for distributed focus control with slope tracking
US5938607A (en) * 1996-09-25 1999-08-17 Atl Ultrasound, Inc. Ultrasonic diagnostic imaging system with access to reference image library
US6095976A (en) * 1997-06-19 2000-08-01 Medinol Ltd. Method for enhancing an image derived from reflected ultrasound signals produced by an ultrasound transmitter and detector inserted in a bodily lumen
WO1999005640A1 (en) * 1997-07-25 1999-02-04 Arch Development Corporation Method and system for the segmentation of lung regions in lateral chest radiographs
US6106465A (en) * 1997-08-22 2000-08-22 Acuson Corporation Ultrasonic method and system for boundary detection of an object of interest in an ultrasound image
US5957138A (en) * 1997-08-25 1999-09-28 Diasonics Ultrasound, Inc. Method and apparatus for three-dimensional flow lumen imaging
US6148095A (en) * 1997-09-08 2000-11-14 University Of Iowa Research Foundation Apparatus and method for determining three-dimensional representations of tortuous vessels
US5876343A (en) * 1997-09-23 1999-03-02 Scimed Life Systems, Inc. Methods and apparatus for blood speckle detection in an intravascular ultrasound imaging system
US5885218A (en) * 1997-11-07 1999-03-23 Scimed Life Systems, Inc. Method and apparatus for spatial filtering in an intravascular ultrasound imaging system
FR2772590B1 (en) * 1997-12-18 2000-04-14 Michel Puech USE OF AN ULTRASONIC TRANSDUCER FOR ECHOGRAPHIC EXPLORATION OF THE POSTERIOR SEGMENT OF THE EYEBALL
US6106460A (en) * 1998-03-26 2000-08-22 Scimed Life Systems, Inc. Interface for controlling the display of images of diagnostic or therapeutic instruments in interior body regions and related data
US6238342B1 (en) * 1998-05-26 2001-05-29 Riverside Research Institute Ultrasonic tissue-type classification and imaging methods and apparatus
US6063032A (en) * 1998-09-28 2000-05-16 Scimed Systems, Inc. Ultrasound imaging with zoom having independent processing channels
US6120445A (en) * 1998-10-02 2000-09-19 Scimed Life Systems, Inc. Method and apparatus for adaptive cross-sectional area computation of IVUS objects using their statistical signatures
US6398736B1 (en) * 1999-03-31 2002-06-04 Mayo Foundation For Medical Education And Research Parametric imaging ultrasound catheter
US6381350B1 (en) * 1999-07-02 2002-04-30 The Cleveland Clinic Foundation Intravascular ultrasonic analysis using active contour method and system
US6200268B1 (en) 1999-09-10 2001-03-13 The Cleveland Clinic Foundation Vascular plaque characterization
US6264609B1 (en) * 1999-09-15 2001-07-24 Wake Forest University Ultrasound apparatus and method for tissue characterization
US6306089B1 (en) * 1999-09-24 2001-10-23 Atl Ultrasound, Inc. Ultrasonic diagnostic imaging system with customized measurements and calculations
US6454715B2 (en) * 2000-04-11 2002-09-24 Scimed Life Systems, Inc. Methods and apparatus for blood speckle detection in an intravascular ultrasound imaging system
US6561980B1 (en) * 2000-05-23 2003-05-13 Alpha Intervention Technology, Inc Automatic segmentation of prostate, rectum and urethra in ultrasound imaging
US6450960B1 (en) * 2000-08-29 2002-09-17 Barbara Ann Karmanos Cancer Institute Real-time three-dimensional acoustoelectronic imaging and characterization of objects
WO2002023483A2 (en) * 2000-09-14 2002-03-21 Leland Stanford Junior University Technique for manipulating medical images
US6785409B1 (en) * 2000-10-24 2004-08-31 Koninklijke Philips Electronics, N.V. Segmentation method and apparatus for medical images using diffusion propagation, pixel classification, and mathematical morphology
JP4614548B2 (en) * 2001-01-31 2011-01-19 パナソニック株式会社 Ultrasonic diagnostic equipment
US20030032880A1 (en) 2001-06-13 2003-02-13 Pauliina Moore Apparatus and method for ultrasonically identifying vulnerable plaque
DE10210648A1 (en) * 2002-03-11 2003-10-02 Siemens Ag Medical 3-D imaging method for organ and catheter type instrument portrayal in which 2-D ultrasound images, the location and orientation of which are known, are combined in a reference coordinate system to form a 3-D image
EP1345154A1 (en) * 2002-03-11 2003-09-17 Bracco Imaging S.p.A. A method for encoding image pixels and method for processing images aimed at qualitative recognition of the object reproduced by one more image pixels
US7074188B2 (en) 2002-08-26 2006-07-11 The Cleveland Clinic Foundation System and method of characterizing vascular tissue
TR201902962T4 (en) * 2002-08-26 2019-03-21 Cleveland Clinic Found System and method for characterizing vascular tissue.
US7927275B2 (en) 2002-08-26 2011-04-19 The Cleveland Clinic Foundation System and method of aquiring blood-vessel data
US7359554B2 (en) * 2002-08-26 2008-04-15 Cleveland Clinic Foundation System and method for identifying a vascular border
US6824514B2 (en) * 2002-10-11 2004-11-30 Koninklijke Philips Electronics N.V. System and method for visualizing scene shift in ultrasound scan sequence
US6835177B2 (en) * 2002-11-06 2004-12-28 Sonosite, Inc. Ultrasonic blood vessel measurement apparatus and method
US7175597B2 (en) * 2003-02-03 2007-02-13 Cleveland Clinic Foundation Non-invasive tissue characterization system and method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478219A (en) * 1982-03-24 1984-10-23 Manuel Dujovny Temporary microvascular occluder
US5657760A (en) * 1994-05-03 1997-08-19 Board Of Regents, The University Of Texas System Apparatus and method for noninvasive doppler ultrasound-guided real-time control of tissue damage in thermal therapy
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US7070595B2 (en) * 1998-12-14 2006-07-04 Medwaves, Inc. Radio-frequency based catheter system and method for ablating biological tissues
US6475149B1 (en) * 2001-09-21 2002-11-05 Acuson Corporation Border detection method and system
US20050027188A1 (en) * 2002-12-13 2005-02-03 Metaxas Dimitris N. Method and apparatus for automatically detecting breast lesions and tumors in images

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070127756A1 (en) * 2005-12-07 2007-06-07 Siemens Corporate Research, Inc. Method and Apparatus for Ear Canal Surface Modeling Using Optical Coherence Tomography Imaging
US8135453B2 (en) * 2005-12-07 2012-03-13 Siemens Corporation Method and apparatus for ear canal surface modeling using optical coherence tomography imaging
US20120275672A1 (en) * 2006-05-22 2012-11-01 Upmc System and Method for Improved Viewing and Navigation of Digital Images
US8417006B2 (en) * 2006-05-22 2013-04-09 Upmc System and method for improved viewing and navigation of digital images
US9867530B2 (en) 2006-08-14 2018-01-16 Volcano Corporation Telescopic side port catheter device with imaging system and method for accessing side branch occlusions
US10219780B2 (en) 2007-07-12 2019-03-05 Volcano Corporation OCT-IVUS catheter for concurrent luminal imaging
US9596993B2 (en) 2007-07-12 2017-03-21 Volcano Corporation Automatic calibration systems and methods of use
US11350906B2 (en) 2007-07-12 2022-06-07 Philips Image Guided Therapy Corporation OCT-IVUS catheter for concurrent luminal imaging
US9622706B2 (en) 2007-07-12 2017-04-18 Volcano Corporation Catheter for in vivo imaging
US10987086B2 (en) 2009-10-12 2021-04-27 Acist Medical Systems, Inc. Intravascular ultrasound system for co-registered imaging
US11141063B2 (en) 2010-12-23 2021-10-12 Philips Image Guided Therapy Corporation Integrated system architectures and methods of use
US11040140B2 (en) 2010-12-31 2021-06-22 Philips Image Guided Therapy Corporation Deep vein thrombosis therapeutic methods
US9360630B2 (en) 2011-08-31 2016-06-07 Volcano Corporation Optical-electrical rotary joint and methods of use
US10070827B2 (en) 2012-10-05 2018-09-11 Volcano Corporation Automatic image playback
US9324141B2 (en) 2012-10-05 2016-04-26 Volcano Corporation Removal of A-scan streaking artifact
US11864870B2 (en) 2012-10-05 2024-01-09 Philips Image Guided Therapy Corporation System and method for instant and automatic border detection
US9292918B2 (en) 2012-10-05 2016-03-22 Volcano Corporation Methods and systems for transforming luminal images
US11510632B2 (en) 2012-10-05 2022-11-29 Philips Image Guided Therapy Corporation Systems for indicating parameters in an imaging data set and methods of use
US20140100440A1 (en) * 2012-10-05 2014-04-10 Volcano Corporation System and method for instant and automatic border detection
US9367965B2 (en) 2012-10-05 2016-06-14 Volcano Corporation Systems and methods for generating images of tissue
US11890117B2 (en) 2012-10-05 2024-02-06 Philips Image Guided Therapy Corporation Systems for indicating parameters in an imaging data set and methods of use
WO2014055923A3 (en) * 2012-10-05 2015-07-23 Elizabeth Begin System and method for instant and automatic border detection
US9286673B2 (en) 2012-10-05 2016-03-15 Volcano Corporation Systems for correcting distortions in a medical image and methods of use thereof
US11272845B2 (en) * 2012-10-05 2022-03-15 Philips Image Guided Therapy Corporation System and method for instant and automatic border detection
US9858668B2 (en) 2012-10-05 2018-01-02 Volcano Corporation Guidewire artifact removal in images
US9307926B2 (en) 2012-10-05 2016-04-12 Volcano Corporation Automatic stent detection
US9478940B2 (en) 2012-10-05 2016-10-25 Volcano Corporation Systems and methods for amplifying light
US10568586B2 (en) 2012-10-05 2020-02-25 Volcano Corporation Systems for indicating parameters in an imaging data set and methods of use
US10724082B2 (en) 2012-10-22 2020-07-28 Bio-Rad Laboratories, Inc. Methods for analyzing DNA
US10238367B2 (en) 2012-12-13 2019-03-26 Volcano Corporation Devices, systems, and methods for targeted cannulation
US11141131B2 (en) 2012-12-20 2021-10-12 Philips Image Guided Therapy Corporation Smooth transition catheters
US9730613B2 (en) 2012-12-20 2017-08-15 Volcano Corporation Locating intravascular images
US10939826B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Aspirating and removing biological material
US9709379B2 (en) 2012-12-20 2017-07-18 Volcano Corporation Optical coherence tomography system that is reconfigurable between different imaging modes
US10942022B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Manual calibration of imaging system
US11406498B2 (en) 2012-12-20 2022-08-09 Philips Image Guided Therapy Corporation Implant delivery system and implants
US11892289B2 (en) 2012-12-20 2024-02-06 Philips Image Guided Therapy Corporation Manual calibration of imaging system
US10595820B2 (en) 2012-12-20 2020-03-24 Philips Image Guided Therapy Corporation Smooth transition catheters
US10332228B2 (en) 2012-12-21 2019-06-25 Volcano Corporation System and method for graphical processing of medical data
US10413317B2 (en) 2012-12-21 2019-09-17 Volcano Corporation System and method for catheter steering and operation
US9383263B2 (en) 2012-12-21 2016-07-05 Volcano Corporation Systems and methods for narrowing a wavelength emission of light
US10420530B2 (en) 2012-12-21 2019-09-24 Volcano Corporation System and method for multipath processing of image signals
US9486143B2 (en) 2012-12-21 2016-11-08 Volcano Corporation Intravascular forward imaging device
US10166003B2 (en) 2012-12-21 2019-01-01 Volcano Corporation Ultrasound imaging with variable line density
US11786213B2 (en) 2012-12-21 2023-10-17 Philips Image Guided Therapy Corporation System and method for multipath processing of image signals
US10191220B2 (en) 2012-12-21 2019-01-29 Volcano Corporation Power-efficient optical circuit
US9612105B2 (en) 2012-12-21 2017-04-04 Volcano Corporation Polarization sensitive optical coherence tomography system
US10058284B2 (en) 2012-12-21 2018-08-28 Volcano Corporation Simultaneous imaging, monitoring, and therapy
US11253225B2 (en) 2012-12-21 2022-02-22 Philips Image Guided Therapy Corporation System and method for multipath processing of image signals
US10993694B2 (en) 2012-12-21 2021-05-04 Philips Image Guided Therapy Corporation Rotational ultrasound imaging catheter with extended catheter body telescope
US10226597B2 (en) 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
US9770172B2 (en) 2013-03-07 2017-09-26 Volcano Corporation Multimodal segmentation in intravascular images
US11154313B2 (en) 2013-03-12 2021-10-26 The Volcano Corporation Vibrating guidewire torquer and methods of use
US10638939B2 (en) 2013-03-12 2020-05-05 Philips Image Guided Therapy Corporation Systems and methods for diagnosing coronary microvascular disease
US10758207B2 (en) 2013-03-13 2020-09-01 Philips Image Guided Therapy Corporation Systems and methods for producing an image from a rotational intravascular ultrasound device
US9301687B2 (en) 2013-03-13 2016-04-05 Volcano Corporation System and method for OCT depth calibration
US11026591B2 (en) 2013-03-13 2021-06-08 Philips Image Guided Therapy Corporation Intravascular pressure sensor calibration
US10426590B2 (en) 2013-03-14 2019-10-01 Volcano Corporation Filters with echogenic characteristics
US10219887B2 (en) 2013-03-14 2019-03-05 Volcano Corporation Filters with echogenic characteristics
US10292677B2 (en) 2013-03-14 2019-05-21 Volcano Corporation Endoluminal filter having enhanced echogenic properties
US10653393B2 (en) 2015-10-08 2020-05-19 Acist Medical Systems, Inc. Intravascular ultrasound imaging with frequency selective imaging methods and systems
US10909661B2 (en) * 2015-10-08 2021-02-02 Acist Medical Systems, Inc. Systems and methods to reduce near-field artifacts
US20170103498A1 (en) * 2015-10-08 2017-04-13 Acist Medical Systems, Inc. Systems and methods to reduce near-field artifacts
US11369337B2 (en) 2015-12-11 2022-06-28 Acist Medical Systems, Inc. Detection of disturbed blood flow
US20170330331A1 (en) 2016-05-16 2017-11-16 Acist Medical Systems, Inc. Motion-based image segmentation systems and methods
US10489919B2 (en) 2016-05-16 2019-11-26 Acist Medical Systems, Inc. Motion-based image segmentation systems and methods
CN110246136A (en) * 2019-05-29 2019-09-17 山东大学 A kind of intravascular ultrasound parameter extracting method and system based on hybrid algorithm
US11763460B2 (en) 2019-07-02 2023-09-19 Acist Medical Systems, Inc. Image segmentation confidence determination
US11024034B2 (en) 2019-07-02 2021-06-01 Acist Medical Systems, Inc. Image segmentation confidence determination

Also Published As

Publication number Publication date
WO2005091885A2 (en) 2005-10-06
US20050196026A1 (en) 2005-09-08
WO2005091885A3 (en) 2006-11-02
US7215802B2 (en) 2007-05-08
EP1732461A2 (en) 2006-12-20
JP2007526083A (en) 2007-09-13
EP1732461A4 (en) 2008-05-21
ATE504239T1 (en) 2011-04-15
EP1732461B1 (en) 2011-04-06
DE602005027334D1 (en) 2011-05-19
JP4733107B2 (en) 2011-07-27
US20070071326A1 (en) 2007-03-29
US7463759B2 (en) 2008-12-09

Similar Documents

Publication Publication Date Title
US7463759B2 (en) System and method for vascular border detection
US7359554B2 (en) System and method for identifying a vascular border
US8449465B2 (en) System and method for characterizing vascular tissue
JP2007526083A5 (en)
Katouzian et al. A state-of-the-art review on segmentation algorithms in intravascular ultrasound (IVUS) images
Golemati et al. Using the Hough transform to segment ultrasound images of longitudinal and transverse sections of the carotid artery
US7074188B2 (en) System and method of characterizing vascular tissue
EP1534137B1 (en) System and method for identifying a vascular border
WO2005070300A1 (en) System and method for determining a transfer function
Chandrasekaran et al. Three-dimensional volumetric ultrasound imaging of arterial pathology from two-dimensional intravascular ultrasound: an in vitro study
Ciompi et al. Reconstruction and analysis of intravascular ultrasound sequences
CN105307574B (en) For detecting the method and apparatus of bubble using ultrasound
O'Malley Computational methods for contrast-enhanced intravascular ultrasound sequence analysis
Abreu Automatic Location of Atherosclerotic Plaques by Ultrasounds
Yue Noise suppression and motion estimation in medical ultrasound imaging
Klingensmith Assessment of coronary plaque volume using three-dimensional intravascular ultrasound
Coleman Characterisation of carotid atherosclerotic plaque composition in vivo using 3D B-mode ultrasound
Bravo et al. 3D ultrasound in cardiology

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION